{
    "nctId": "NCT01662284",
    "briefTitle": "Study of 124I-NM404 in Advanced Solid Malignancies",
    "officialTitle": "A Phase 1/2 Study of 124I-NM404 in Subjects With Advanced Solid Malignancies",
    "overallStatus": "TERMINATED",
    "conditions": "Triple Negative Breast, Prostate, Colorectal, Gastric, Ovarian, Pancreatic, Esophageal, Soft Tissue Sarcoma, and Head & Neck Cancer",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 12,
    "primaryOutcomeMeasure": "Optimal Imaging Parameters",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Diagnosis of advanced solid malignancy.\n* Allowed tumor types: triple negative breast, prostate, colorectal, gastric, ovarian, pancreatic, esophageal, soft tissue sarcoma, and head \\& neck cancer\n* Disease must be at least 1cm in diameter\n* Brain metastasis must be stable for at least one month.\n* ECOG performance status 0-2\n* Anticipated survival less than 5 years, as per the treating physician\n\nExclusion Criteria:\n\n* Skin lesions only\n* Chemotherapy or radiotherapy within 1 week\n* Residual toxicities of grade 2 or greater from prior therapy\n* Adequate organ function as per specified laboratory parameter\n* Platelet count \\> or = to 75,000/uL",
    "sex": "ALL",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}